$LPCN
Lipocine Inc.
XNAS•Health Care•Pharmaceutical Preparations
$2.21
▼-0.45%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is LPCN down today? It is at $2.21 (-0.45%). See the catalyst behind the move, real-time alerts the moment LPCN spikes, and full due diligence on LPCN — key stats, earnings, dilution and insider activity. Free.
Be first to know when $LPCN makes an unusual move. Create a free account to track $LPCN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LPCN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LPCN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Higuchi John W. Director | Bought (open market) | +40K 0.5% of company | added 24% | 204K | $81K at $2.03 | Apr 7, 26 |
Patel Mahesh V. Officer | Bought (open market) | +25K 0.3% of company | added 18% | 161K | $51K at $2.03 | Apr 6, 26 |
Higuchi John W. Director | Bought (open market) | +123K 1.5% of company | added 100% | 164K | $252K at $2.05 | Apr 6, 26 |
Patel Mahesh V. Officer | Bought (open market) | +25K 0.3% of company | added 23% | 136K | $51K at $2.02 | Apr 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LPCN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LPCN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LPCN last traded at $2.21, down 0.45% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lipocine Inc. (LPCN) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LPCN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LPCN 0 times in the last 30 days.
LPCN (Lipocine Inc.) trades on XNAS, with a market cap of about $18M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LPCN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LPCN discussion
Sign in to ask a question or join the discussion.